Live
ePaper
Search
Home > India > BRIEF-Mira Pharmaceuticals – Reports Significant Weight And Fat Reduction With Oral Skny-1 In Obese Mice – SEC Filing

BRIEF-Mira Pharmaceuticals – Reports Significant Weight And Fat Reduction With Oral Skny-1 In Obese Mice – SEC Filing

Written By:
Last Updated: October 29, 2026 01:58:47 IST

Oct 28 (Reuters) – Mira Pharmaceuticals Inc: * MIRA PHARMACEUTICALS – REPORTS SIGNIFICANT WEIGHT AND FAT REDUCTION WITH ORAL SKNY-1 IN OBESE MICE – SEC FILING * MIRA PHARMACEUTICALS – SKNY-1 WEIGHT

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?